The Prediction Potential of the Pretreatment Lung Immune Prognostic Index for the Therapeutic Outcomes of Immune Checkpoint Inhibitors in Patients With Solid Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: The lung immune prognostic index (LIPI) is recently developed to predict immune checkpoint inhibitors (ICIs) treatment outcomes for non-small cell lung cancer. However, its predictive value for other types of cancer remained unclear. This meta-analysis aimed to evaluate the association b...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hui, Yang, Xiao-Li, Yang, Xiao-Yun, Dong, Zhao-Ru, Chen, Zhi-Qiang, Hong, Jian-Guo, Li, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496897/
https://www.ncbi.nlm.nih.gov/pubmed/34631525
http://dx.doi.org/10.3389/fonc.2021.691002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496897/
https://www.ncbi.nlm.nih.gov/pubmed/34631525
http://dx.doi.org/10.3389/fonc.2021.691002

Ejemplares similares